retatrutide phase 2 results obesity nejm 2023 Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care Retatrutide vs Mounjaro | Best
Description
[3] [5] For patients with LDL-C 190 mg/dL, high-intensity statins are first-line therapy, with consideration of ezetimibe, bempedoic acid, or PCSK9 inhibitors for additional lowering
One study concluded that t wo-thirds of the weight loss was regained after one year off GLP-1
( 10.1161/CIRCHEARTFAILURE.108.766402) [DOI] [PMC free article] [PubMed] [Google Scholar] Pujadas G Baggio LL Kaur KD McLean BA Cao X & Drucker DJ
This way, treatment can fit the needs and goals of each person
Viramontes, B
These results demonstrate that d-allulose improves glucose tolerance via potentiation of GLP-1R signaling
